Skip to content
Conference Open access

The role of artificial intelligence in health insurance systems for managing multimorbidity (communicable and non-communicable diseases) in older adults: A scoping review

2026 · BIO Web of Conferences · 0 citations · 14 references

TL;DR

Robust governance, explainable AI (XAI), and effective human monitoring are essential for safeguarding vulnerable elderly populations and improving health equity.

Abstract

The aging population is fueling geriatric multimorbidity—the confluence of communicable and noncommunicable diseases—which is putting strain on health insurance ecosystems. In accordance with the Sustainable Development Goals (SDGs 3 and 10), this assessment looks into the use of Artificial Intelligence (AI) to manage these problems and ensure fair treatment. Following PRISMA-ScR guidelines, a systematic search of important databases (PubMed, Scopus, Web of Science, and EMBASE) was conducted for literature published between 2016 and 2026. Out of 1,245 initial screened data, 15 relevant studies were discovered and examined. AI drives three major innovations: (1) ensemble machine learning algorithms (e.g., XGBoost) outperform traditional actuarial models in predicting claim costs; (2) clinical AI optimizes polypharmacy and speeds up early infectious disease detection; and (3) automated machine learning architectures provide robust claim fraud detection. However, algorithmic bias and opaque usage management strategies for care denial cause severe ethical concerns. While AI increases financial and clinical efficiency, its application must extend beyond cost containment. Robust governance, explainable AI (XAI), and effective human monitoring are essential for safeguarding vulnerable elderly populations and improving health equity.

Read PDF

Similar papers

Review Open access Aug 2026

A systematic review of artificial intelligence and machine learning for public health predictions using electronic health records in low and middle income countries with comparative benchmarks from high income settings

This review synthesises studies on ML-based prediction using EHR or routinely collected electronic clinical data, with direct LMIC evidence analysed alongside high-income country (HIC) studies, included as methodological benchmarks.

Joe Phiri, Aaron Zimba, C. Njovu et al. · 0 citations
Review Open access Aug 2026

Machine Learning and Explainable Artificial Intelligence for Early Heart Disease Prediction and Clinical Decision Support: A Systematic Review

This systematic review examines contemporary machine learning methods and explainable AI procedures engaged prediction of heart diseases and classification and applies explainability AI heart disease prediction models that will ease the process and also make the upcoming system with better progress and more trustworthy...

R. Jain, Sachin H. Patel · 0 citations
Review Open access Sep 2026

Artificial Intelligence Algorithms for Early Detection and Risk Stratification of Type 2 Diabetes Mellitus, Multimodal Bioinformatic Phenotyping, and Its Complications: A Technical Review of Classical Machine Learning, Deep Learning, and Post-Hoc Feature Attribution

Overall, AI stands out as a viable and scalable complement to conventional screening, although gaps remain in multicentre prospective validation, reporting standardisation, and algorithmic equity across populations.

Kattia Orozco-Romero, Jonas Pariona-Torres, Jose Cornejo · 0 citations
Review Sep 2026

Artificial Intelligence–Driven Prediction and Management of Chronic Diseases: A Comparative Analysis of Diabetes, Cardiovascular Disease, and Cancer

Artificial intelligence (AI) is increasingly used to convert heterogeneous clinical data into actionable predictions across chronic disease pathways, yet the maturity and clinical role of AI differ substantially among diabetes, cardiovascular disease (CVD), and cancer. This structured comparative evidence synthesis eva...

Reshmi Gopalakrishnan · 0 citations
#artificial intelligence Review Open access Sep 2026

Factors affecting the prediction of health care costs in cardiovascular patients using artificial intelligence tools: a systematic review of regression and machine learning approaches

The most significant factors influencing health care costs were age, gender, type of cardiovascular procedure, comorbidities, length of hospitalization, and complications, while machine learning models showed superior accuracy in some studies compared with traditional regression methods for predicting healthcare costs...

Alireza Banaye Yazdipour, Mohammad Amiri-Ara, Parisa Mehdizadeh · 0 citations
Open access Aug 2026

Cost-Effectiveness of an Artificial Intelligence as a Medical Device (AIaMD) for Triaging Patients Presenting to Primary Care with Concerns that They Have a Skin Cancer: A Modelling Study.

INTRODUCTION Health services are struggling to cope with the growing numbers of people coming with skin lesions they are worried could be cancer. Using artificial intelligence (AI) to assist in the triage process is one potential approach. Deep Ensemble for the Recognition of Melanoma (DERM) is one such AI device which...

Javad Javan, Z. Zhelev, B. Grigore et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.